Ozempic 0.5mg Shortage Status October 2026
Pharmaceutical availability gaps remain a burden on people across the country. This page provides current data on stock status and options.
Current Availability
As of October 2026, availability for GLP-1 medications is highly variable by:
- Drug and dose: Starting strengths are often more available than higher strengths
- Geographic location: Supply chains send more stock to high-volume markets while less populated regions see more shortages
- Retail vs specialty: Specialty pharmacies occasionally access what chain pharmacies can’t get
Dose-Specific Tracking
Beginning Doses
Low-dose strengths are usually in better supply because:
- Fewer patients uses starting strength long-term
- Pharma companies prioritize starter doses to ensure onboarding capability
Maintenance and Higher Doses
Maintenance strengths face more pressure because:
- The majority of users accumulate at these strengths and continue long-term
- Production can’t keep up with growing demand
Action Plan
Immediate Steps
- Phone before visiting — avoid going to any location without confirming availability
- Cast a wide net — call at least 5 locations not just chains
- Get on a notification list — certain stores will notify you when stock arrives
Extended Supply Issues
- Reach out to your provider about alternative dosing — your prescriber could prescribe dose splitting
- Explore compounded alternatives — if the drug is on the FDA shortage list, compounded versions can be prescribed
- Try patient support programs — both Novo Nordisk and Eli Lilly have resources to help patients find supply
Monitoring Resources
Monitor these channels to stay informed:
- The official FDA list — the authoritative source
- Drug maker supply pages — supply updates straight from the companies
- Retail pharmacy apps — can indicate stock availability
- Online forums — other patients post current stock findings
We refresh this tracker as conditions change.